×
EnVVeno Medical Net Profit Margin 2017-2024 | NVNO
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Profit Margins
Gross Margin
Operating Margin
EBITDA Margin
Pre-Tax Margin
Net Margin
EnVVeno Medical net profit margin from 2017 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.
View More
EnVVeno Medical Net Profit Margin 2017-2024 | NVNO
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Profit Margins
Gross Margin
Operating Margin
EBITDA Margin
Pre-Tax Margin
Net Margin
EnVVeno Medical net profit margin from 2017 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.
Related Stocks
Company Name
Market
Cap
Thermo Fisher Scientific (TMO)
$196.3B
Intuitive Surgical (ISRG)
$195.1B
Alcon (ALC)
$42.4B
Edwards Lifesciences (EW)
$41.6B
IQVIA Holdings (IQV)
$36.6B
IDEXX Laboratories (IDXX)
$34.2B
DexCom (DXCM)
$28.4B
Waters (WAT)
$22.2B
STERIS (STE)
$21.2B
SONOVA HOLDING (SONVY)
$20.8B
Hologic (HOLX)
$18.3B
Fresenius Medical Care AG KGaA (FMS)
$13B
Sysmex ADR (SSMXY)
$12.9B
Globus Medical (GMED)
$11.5B
Penumbra (PEN)
$9.4B
Masimo (MASI)
$9.3B
Teleflex (TFX)
$8.9B
Glaukos (GKOS)
$7.9B
PROCEPT BioRobotics (PRCT)
$4.9B
Integer Holdings (ITGR)
$4.6B
Veracyte (VCYT)
$3.1B
Inari Medical (NARI)
$2.9B
LivaNova (LIVN)
$2.8B
TransMedics (TMDX)
$2.6B
Nihon Kohden (NHNKY)
$2.5B
Elekta AB (EKTAY)
$2.2B
Tandem Diabetes Care (TNDM)
$2B
Integra LifeSciences Holdings (IART)
$1.8B
RxSight (RXST)
$1.8B
Alphatec Holdings (ATEC)
$1.4B